BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pathology News
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260519
DTEND;VALUE=DATE:20260522
DTSTAMP:20260826T233116
CREATED:20260305T112346Z
LAST-MODIFIED:20260305T112346Z
UID:100119129-1779148800-1779407999@www.pathologynews.com
SUMMARY:HIMSS Europe 2026
DESCRIPTION:0000Days00Hrs00Min00Sec\n\nEXPERT INSIGHTS\, EXCEPTIONAL IMPACT\n\n\n\n\nHIMSS26 Europe is more than just a conference—it’s a movement toward smarter\, more efficient healthcare. Whether you’re looking to understand emerging tech trends\, improve your organization’s digital readiness\, or discover real-world applications of health IT\, HIMSS26 Europe puts you at the center of healthcare’s digital evolution.\n\n\n\n\nWhether you’re a healthcare provider\, technology innovator\, policy maker or business leader\, HIMSS26 Europe is your gateway to the latest insights on how digital transformation is revolutionizing patient care\, operational efficiency and overall health outcomes. Don’t miss our visionary keynotes\, hands-on workshops and unparalleled networking opportunities. \nIn Copenhagen\, we’ll explore the latest trends\, solutions and strategies in health tech. With insightful keynotes\, hands-on workshops and unparalleled networking opportunities\, this event is designed to accelerate your understanding of digital maturity in healthcare—and how you can leverage it to stay ahead of the curve. \n\n\nWhy attend:\n\nExplore Groundbreaking Innovations\nHear from Global Experts\nMake New Connections\nGain Actionable Insights\n\nRegister Now
URL:https://www.pathologynews.com/event/himss-europe-2026/
LOCATION:Bella Center\, Copenhagen\, Center Boulevard 5\, Copenhagen\, 2300\, Denmark
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/webp:https://www.pathologynews.com/wp-content/uploads/2026/03/HIMSS-Europe-2026.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260518
DTEND;VALUE=DATE:20260522
DTSTAMP:20260826T233116
CREATED:20260106T145515Z
LAST-MODIFIED:20260106T145515Z
UID:100117704-1779062400-1779407999@www.pathologynews.com
SUMMARY:Association of Pathology Informatics (API) Summit 2026
DESCRIPTION:0000Days00Hrs00Min00SecWhat is the API Summit?\nThe API Summit continues its proud tradition of convening the foremost thought leaders and innovators in clinical laboratory and anatomic pathology informatics. \nEach year\, the Summit offers a comprehensive program of forward-thinking sessions across disciplines\, including:\n• Laboratory Medicine\n• Anatomic Pathology\n• Digital Imaging and Machine Vision\n• Molecular and Genomic Pathology\n• Operations and Business Analytics\n• Education and Training\n• Artificial Intelligence and Machine Learning\n• Regulatory Issues and Standards\n• And much more… \nAs digital pathology advances and laboratory-driven precision medicine transforms clinical practice\, pathology informatics has become the central nervous system of modern healthcare. It governs how diagnostic data is generated\, analyzed\, and shared—directly shaping the flow of patients through the therapeutic process. From the moment a specimen is collected to the initiation of a targeted treatment plan\, informatics ensures that information moves accurately\, securely\, and efficiently. The efficiency of this flow is essential to quality\, impacting everything from diagnostic turnaround time to clinical decision-making and patient outcomes. \nRegister NowTarget Audience\nPhysicians\, Physician Assistants\, Administrators\, House Officers\, Medical Students\, Technicians\, and Other Healthcare Professionals \nGeneral Conference Objectives\n• Define the rapidly evolving field of Digital Pathology and explore opportunities for accelerated adoption of new workflow models leveraging machine learning\, artificial intelligence\, and integrated hardware solutions.\n• Discuss foundational principles of business analytics\, computational pathology\, and AI integration to support diagnostic excellence and operational efficiency.\n• Identify and evaluate software and hardware innovations through direct engagement with leading exhibitors.\n• Recognize the technical\, regulatory\, and organizational requirements to successfully deploy informatics solutions in the clinical diagnostic environment.\n• Present new research and scientific innovations in pathology informatics through competitive abstract sessions.\n• Provide fundamental informatics education for residents and fellows.\n• Deliver updated best practices in digital pathology validation and primary diagnosis.\n• Explore methods to deploy and sustain large language models (LLMs) for clinical\, educational\, and research use. \nLearning Outcomes\nAfter completing this activity\, participants will be able to:\n1. Identify key trends in data science as applied to digital pathology and laboratory medicine.\n2. Create new opportunities for data management\, interoperability\, and collaboration within healthcare enterprises\n3. Strengthen their clinical informatics and operational efficiency competencies.\n4. Initiate machine learning and AI tool development in their departments or divisions.\n5. Identify and foster mentorship opportunities in pathology informatics.\n6. Develop and expand research collaborations that drive innovation and precision diagnostics.\n7. Understand how informatics-driven patient flow enhances the quality and timeliness of diagnosis and treatment.
URL:https://www.pathologynews.com/event/association-of-pathology-informatics-api-summit-2026/
LOCATION:Renaissance Minneapolis Hotel\, The Depot\, Minneapolis\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/Association-of-Pathology-Informatics-API-Summit-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260514T090000
DTEND;TZID=UTC:20260514T170000
DTSTAMP:20260826T233116
CREATED:20251010T103127Z
LAST-MODIFIED:20260317T221923Z
UID:100116017-1778749200-1778778000@www.pathologynews.com
SUMMARY:Edinburgh: Transforming Digital Pathology & AI: The Path Forward
DESCRIPTION:0000Days00Hrs00Min00SecThis event that brings together researchers\, clinicians and industry specialists to examine the current and emerging role of digital pathology and artificial intelligence in diagnostic practice. \nRecent developments in whole slide imaging\, computational pathology and AI-based analysis are reshaping diagnostic practice and research. This programme brings together methodological\, translational and clinical perspectives to examine how these approaches are being developed\, validated and introduced into routine pathology workflows. \nThe conference will focus on the practical realities of implementation\, including digital infrastructure\, regulatory requirements\, model validation and workforce readiness. Sessions will address how healthcare systems are managing adoption at scale\, and what is needed to move from pilot studies to reliable clinical use. \nEthical\, legal and governance issues form a core part of the programme\, with dedicated discussion on transparency\, accountability and responsibility in AI-supported diagnosis. \n\n\nWhat to expect\n\n\n\n\n\nCase studies and presentations from the experts on applications of AI in digital pathology\n8 CPD Points\nLive interaction with senior speakers\nPanel discussions\nExhibition\nAgenda geared towards networking and close collaboration\n1-2-1 Partnering Meetings\nKeynote across a sit down breakfast\nHands-on product/software demos from the industry’s leading tech providers\nEvening drinks reception and canapés\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/edinburgh-transforming-digital-pathology-ai-the-path-forward/
LOCATION:Scottish Gas Murrayfield Stadium\, Edinburgh\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/Edinburgh-Transforming-Digital-Pathology-AI-The-Path.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260511T140000
DTEND;TZID=UTC:20260511T150000
DTSTAMP:20260826T233116
CREATED:20260423T092530Z
LAST-MODIFIED:20260423T092530Z
UID:100120535-1778508000-1778511600@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series – Computational Pathology for Discovering Biomarkers of Immunotherapy Response in Advanced Melanoma
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Mark Schuiveling from UMC Utrecht\, the Netherlands. \nAbstract\nImmune checkpoint inhibition (ICI) has significantly improved outcomes for patients with advanced cutaneous melanoma\, leading to durable responses and potential long-term remission in approximately half of patients. However\, it is also associated with severe and sometimes irreversible toxicity\, underscoring the need for reliable biomarkers. In our group\, we investigate whether computational pathology approaches add value beyond clinical data for identifying biomarkers associated with treatment response in these patients. In this talk\, I will highlight our work on tumor-infiltrating lymphocytes in melanoma histopathology\, as well as our recent work in the PUMA challenge\, where we assessed whether additional immune cell subsets provide further associated predictive value. \nRegister NowBio\nMark Schuiveling is a medical doctor and PhD candidate at the University Medical Centre Utrecht\, the Netherlands. He is expected to defend his thesis in the summer of 2026 and is currently working as an internal medicine resident\, after which he will begin an oncology fellowship in 2027. His research focuses on melanoma\, in which he and his colleagues have assembled a multicentre dataset of digitized whole-slide images\, CT scans\, and clinical data\, with the aim of improving prediction of response to first-line immune checkpoint inhibition in patients with advanced melanoma. His work has primarily focused on histopathological analysis\, including tumor-infiltrating lymphocyte (TIL) assessment\, as well as on the organization of the PUMA challenge\, which investigated whether additional immune cell subtypes provide added predictive value.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-computational-pathology-for-discovering-biomarkers-of-immunotherapy-response-in-advanced-melanoma/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/04/TIA-Centre-Seminar-Series-Computational-Pathology-for-Discovering-Biomarkers-of-Immunotherapy-Response-in-Advanced-Melanoma.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260507
DTEND;VALUE=DATE:20260509
DTSTAMP:20260826T233116
CREATED:20260107T111116Z
LAST-MODIFIED:20260220T111555Z
UID:100117724-1778112000-1778284799@www.pathologynews.com
SUMMARY:The Digital Pathology & AI Congress USA and American Spatial Biology Congress 2026
DESCRIPTION:0000Days00Hrs00Min00SecOPEN LETTER:\nANIL PARWANI Professor of Pathology and Biomedical Informatics\, Chair of Pathology Department\, The Ohio State University \nDear Colleagues\, \nIt is my great pleasure to offer my full support for the 12th Digital Pathology & AI Congress\, co-located with the 3rd American Spatial Biology Congress\, taking place on May 7–8\, 2026 in Columbus\, Ohio. \nWe are at a defining moment in the evolution of pathology. Digital pathology and artificial intelligence are no longer future concepts—they are actively reshaping how we diagnose disease\, generate knowledge from tissues\, and deliver precision medicine to patients. When combined with advances in spatial biology\, these technologies provide unprecedented insight into tissue architecture\, cellular interactions\, and disease biology across scales. \nAt The Ohio State University\, we have witnessed firsthand how digital pathology and AI can transform clinical workflows\, enable computational discovery\, and bridge research and patient care. From whole-slide imaging and AI-assisted diagnostics to spatial multi-omics and translational research\, these tools are redefining what is possible in modern pathology. Importantly\, their successful adoption depends not only on technological innovation\, but also on collaboration\, shared learning\, and open dialogue across academia\, healthcare\, and industry. \nThis Congress brings together exactly that community. By uniting pathologists\, scientists\, clinicians\, computational experts\, and technology innovators\, the meeting provides a vital forum to explore real-world implementation\, regulatory considerations\, and emerging scientific applications. The co-location of digital pathology and spatial biology is particularly timely\, reflecting how closely these disciplines are converging to drive the next generation of precision diagnostics and therapeutics. \nI am especially pleased that this meeting is being held in Columbus and in collaboration with The Ohio State University. It offers a unique opportunity to engage with leaders while showcasing how integrated digital and spatial approaches are being applied in both research and clinical settings. \nI look forward to participating in the Congress and to delivering the keynote address\, “Journey to Precision Pathology: The Role of Digital Pathology and AI.” I strongly encourage colleagues across pathology\, biomedical research\, and industry to join us for what promises to be an impactful and forward-looking event. \nI hope to see you in Columbus in May 2026. \nAnil Parwani \nRegister Here
URL:https://www.pathologynews.com/event/the-digital-pathology-ai-congress-usa-and-american-spatial-biology-congress-2026/
LOCATION:Columbus\, Ohio\, Columbus\, OH\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/The-Digital-Pathology-AI-Congress-USA-and-American-Spatial-Biology-Congress-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260505T160000
DTEND;TZID=Europe/London:20260505T170000
DTSTAMP:20260826T233116
CREATED:20260330T083139Z
LAST-MODIFIED:20260330T083139Z
UID:100119976-1777996800-1778000400@www.pathologynews.com
SUMMARY:Advancing Precision Medicine Through Pathology and AI-Powered CDx with Indica Labs
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar starts at 8:00 PDT\, 11:00 EDT\, 16:00 BST \nLearn about Indica Labs’ ability to deliver AI-driven CDx\n\n\nSummary\n\n\n\n\nJoin Indica Labs for an exciting webinar on developing AI-powered companion diagnostics in digital pathology. In this comprehensive session\, Indica Labs will introduce its vision for transforming bench to bedside to bench workflows\, take a deep dive into our experience in AI image analysis\, and demonstrate its ability to bring diagnostic products to market. Along the way\, you’ll learn about our experience conducting early proof-of-concept studies\, advancing them to biomarker discovery\, and managing clinical trial assays.   \nDon’t miss this opportunity to hear from senior executives as well as the CEO and Founder of Indica Labs on the topic of developing AI-driven companion diagnostics.  \n\n\nLearning Objectives\n\nLearn about Indica Labs’ initiatives and strategy for developing AI-powered CDx products in digital pathology\nGain insight into Indica Labs’ strategic partnership with Leica Biosystems\nDiscover how Indica Labs can take AI-based early proof-of–concept studies all the way through the development lifecycle to become a regulatory approved CDx\nFind out about deployment options in the CE-IVDR HALO AP® platform\nUnderstand the pathway to regulatory approval for CDx co-developed with Indica Labs and options for additional strategic partnerships\n\nHALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe\, the UK\, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition\, HALO AP® provides built-in compliance with FDA 21 CFR Part 11\, HIPAA\, and GDPR. \nRegister Now\nPresenters\n\nSteven Hashagen \nCEO and Founder\nIndica Labs  \nSteven Hashagen is the founder and CEO of Indica Labs\, a leading digital pathology software and AI company. Prior to forming Indica Labs in 2011\, Steven held software engineering\, software architect\, and product management roles at Aperio Technologies. Through this combined experience Steven has been a pioneer in the digital pathology field for over 20 years.  \nPeter Caie\, PhD\nSr. Director\, Precision Medicine\nIndica Labs \nPeter Caie worked for 9 years as a Senior Scientist at AstraZeneca before completing his PhD from the University of Edinburgh in Cancer Pathology. He went on to run the Quantitative and Digital Pathology (QUAD) Lab at the University of St Andrews where his research focused on artificial intelligence\, cancer prognosis and diagnosis in the field of digital and molecular pathology. Currently\, Dr. Caie is a Senior Director at Indica Labs where he manages the development of commercial AI products\, including CDx assays\, designed for deployment in both the clinical and life science fields.  \nDoug Bowman (Moderator)\nVP Precision Medicine\nIndica Labs  \nDoug is responsible for Indica Labs’ Precision Medicine group that partners with pharma companies to bring new AI-powered companion diagnostics to market. His team leads the commercial development of clinical AI solutions that deploy in HALO AP® and span laboratory operations to clinical research and diagnostic use cases. His Pharma Services team\, with deep experience in quantitative image analysis services\, supports customers’ pre-clinical and clinical biomarker assays. Prior to Indica Labs\, he spent 12+ years at Takeda Pharmaceuticals where he led the tissue-based imaging capabilities to support early discovery\, translational\, and clinical programs. Doug has a BSE in biomedical and electrical engineering from Duke University. 
URL:https://www.pathologynews.com/event/advancing-precision-medicine-through-pathology-and-ai-powered-cdx-with-indica-labs/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/Advancing-Precision-Medicine-Through-Pathology-and-AI-Powered-CDx-with-Indica-Labs.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260501
DTEND;VALUE=DATE:20260503
DTSTAMP:20260826T233116
CREATED:20260225T143735Z
LAST-MODIFIED:20260225T143735Z
UID:100118906-1777593600-1777766399@www.pathologynews.com
SUMMARY:2026 Digital Pathology Course
DESCRIPTION:0000Days00Hrs00Min00SecDigital pathology is rapidly emerging as a new standard of care\, enabling the scanning\, review\, and storage of pathology slides in a fully digital format. These digital workflows enhance patient care through rapid\, reliable image retrieval; support remote review and telepathology; enable the use of computational and AI-assisted tools; and facilitate seamless sharing of cases for consultation\, collaboration\, and education. \nMemorial Sloan Kettering Cancer Center (MSK) has been a leader in digital pathology adoption since 2006 and has digitized more than 10 million slides across multiple platforms. The operational expertise and real-world lessons learned at MSK provide a practical roadmap for institutions seeking to implement or expand digital pathology programs. \nThis two-day\, in-person course\, presented by the MSK Department of Pathology and Laboratory Medicine in collaboration with the Digital Pathology Association (DPA)\, will provide participants the opportunity to learn of new advances in the field as well as engage with other pathologists and researchers in field. \nObjectives\n\nDescribe digital pathology history and integration in pathology practice\nExplain the validation process required for clinical grade digital pathology\nDiscuss digital pathology role in clinical\, educational and research use cases\nSurvey the digital pathology laboratory facilities and view digital tools used in the digital workflows\nRecognize the financial cost of digital pathology implementation\n\nRegister NowProgram Highlights\n\n\n\nPresentations and interactive discussions facilitated by MSK faculty on the practical implementation of digital pathology\, including infrastructure design\, workflow validation\, regulatory considerations\, AI-enabled tools\, and operational and financial planning.\nAn interactive panel discussion\, featuring digital pathology leaders from Memorial Sloan Kettering Cancer Center\, NewYork-Presbyterian Hospital / Weill Cornell Medicine\, Mount Sinai Health System\, Northwell Health\, and NYU Langone Health.\nOptional guided tour and live demonstration of the MSK Digital Pathology Laboratory highlighting high-volume scanning operations and preanalytical workflow modifications (limited to 60 participants).\nAn introduction to the Digital Pathology Association.\nComplimentary networking reception on Friday evening\, providing an opportunity for discussion and professional connections.\nAn online syllabus will be made available to all attendees following the course and will include select PDFs of faculty presentation slides.\n\n\n\nThis activity is designed for pathologists and researchers interested in large-scale digital pathology operations and the clinical implementation of digital pathology and AI-enabled tools.
URL:https://www.pathologynews.com/event/2026-digital-pathology-course/
LOCATION:Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/02/2026-Digital-Pathology-Course.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260428T160000
DTEND;TZID=Europe/London:20260428T170000
DTSTAMP:20260826T233116
CREATED:20260416T091002Z
LAST-MODIFIED:20260416T093435Z
UID:100120322-1777392000-1777395600@www.pathologynews.com
SUMMARY:Inside Concentriq: The Product Behind the Top KLAS Score
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar will start at 11am ET\, 4pm BST \nDigital Pathology Built for Real-World Practice\nAs digital pathology moves into daily practice\, the standard for what a platform should deliver is rising: an experience that works the way pathologists think\, operations that grow with the lab\, and AI that fits naturally into the workflow. \nProscia built Concentriq to that standard\, and continues to evolve it alongside the customers who use it every day. As a result\, Proscia’s customers told KLAS they trust Concentriq\, rating Proscia the top-performing digital pathology vendor across the US¹ and Europe.² \nJoin Proscia’s product team for a look at how the platform works in practice across academic medical centers\, health systems\, and reference labs — and a sneak peek at what we’re building next. Plus\, you’ll hear from guest speaker Daniel Roberts\, MD\, Medical Director of Digital Pathology at Cleveland Clinic\, on what digital pathology adoption and change management actually looks like in practice at one of the nation’s largest academic medical centers. \nRecommended for: Pathology leaders\, laboratory operations teams\, IT and informatics professionals\, and digital pathology leaders evaluating or expanding digital pathology programs. \nRegister NowPresenters\n\nDr. Daniel Roberts\nMedical Director of Digital Pathology\nCleveland Clinic\n\nAmanda Coble\nSenior Director of Product\nProscia\n\nPradyuman Kodavatiganti\nSenior Product Designer\nProscia\n\n\nAshley Faber\nSenior Director of Product Marketing\nProscia
URL:https://www.pathologynews.com/event/inside-concentriq-the-product-behind-the-top-klas-score/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/04/Inside-Concentriq-The-Product-Behind-the-Top-KLAS-Score.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260501
DTSTAMP:20260826T233116
CREATED:20251031T090304Z
LAST-MODIFIED:20260207T112700Z
UID:100116521-1777334400-1777593599@www.pathologynews.com
SUMMARY:2nd African Congress of Digital Pathology - AFCDP 2026
DESCRIPTION:0000Days00Hrs00Min00SecRegister Here
URL:https://www.pathologynews.com/event/2nd-afsdp-congress/
LOCATION:Venue Sofitel Royal Bay Resort\, Agadir\, Agadir\, Morocco
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/2nd-AFSDP-Congress.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260430
DTSTAMP:20260826T233116
CREATED:20251009T094843Z
LAST-MODIFIED:20251009T094843Z
UID:100115997-1777334400-1777507199@www.pathologynews.com
SUMMARY:31st Annual Executive War College
DESCRIPTION:Executive War College\nOn Diagnostics\, Clinical Laboratory\, and Pathology Management\nFor you and your clinical lab or pathology management team\, this must-attend two-day event is unique because it emphasizes success stories and case studies that will help your lab survive—and thrive—despite the industry’s changing landscape. More than 90 sessions and 146 speakers\, panelists\, and lab experts will be at the podium sharing the inside story of how their respective lab organizations are succeeding. \nImportant presentations will cover the major trends in today’s healthcare system and describe specific ways these developments either hurt or help the financial stability of laboratories. \nWhatever your special interest\, you’ll find it! Each day’s sessions cover the full gamut of lab strategy\, lab management\, lab operations\, finance\, sales\, marketing\, managed care contracting\, regulatory\, CLIA updates\, legal/regulatory compliance\, coding/billing/collection innovations\, AI\, digital pathology\, whole genome sequencing\, and even merger & acquisition activity involving lab companies. \nAdd it up! Our Executive War College provides you everything you need to guide your laboratory to success. In two-information-filled days\, you get the latest in lab management\, inside news on breaking trends\, and the opportunity to network with the keenest minds in laboratory medicine. \nRegister Now\n\n\nTop 10 Reasons to Attend the Executive War College\n\n\n\n\n\n\n\n\n1) Get Critical Updates on Key Trends in Laboratory Medicine & Healthcare\n\n\n\n\nYour best opportunity to stay updated with the latest trends reshaping the industry including insights into the latest technologies\, tools\, and strategies labs need to know to maintain financial stability. \n\n\n\n\n\n\n\n\n\n\n\n\n2) Meet Experts & Influencers Face to Face\n\n\n\n\nYou’ll connect with the management leaders at many of the nation’s leading clinical laboratory organizations\, many of whom don’t regularly attend scientific meetings other than the Executive War College. \n\n\n\n\n\n\n\n\n\n\n\n\n3) Learn New Approaches and Ideas in Lab Management\n\n\n\n\nIn addition to sessions about the trends in the clinical laboratory industry and healthcare\, there are more sessions devoted to every aspect of lab operations\, workflow\, billing/coding/collections\, managed care contracting\, lab automation\, and more.  \n\n\n\n\n\n\n\n\n\n\n\n\n4) Develop your Strategic Thinking and Management Skills\n\n\n\n\nUncover new approaches and ideas for improving your laboratory’s quality and financial performance through direct insight into how early adopter laboratories are successfully deploying new diagnostic technologies\, automation\, information technology solutions\, and more. \n\n\n\n\n\n\n\n\n\n\n\n\n5) Benefit From the Energy of Like-Minded Individuals\n\n\n\n\nYou know there is nothing more energizing than being in a room of like-minded people. Like you\, they are willing to take time away from the office to learn something new and readily share their enthusiasm and lessons learned so you can take the best ideas back to your laboratory. \n\n\n\n\n\n\n\n\n\n\n\n\n6) Discuss and Debate Hot Topics with the Industry’s Best and Brightest\n\n\n\n\nOne of the best ways to digest new information and gain new perspectives is to engage in back and forth with other professionals and colleagues. \n\n\n\n\n\n\n\n\n\n\n\n\n7) Connect and Collaborate with your Industry Peers\n\n\n\n\nEngage in a gathering devoted to excellence in the management\, operations\, and financial performance of top-flight laboratory organizations. \n\n\n\n\n\n\n\n\n\n\n\n\n8) Invest In Yourself!\n\n\n\n\nYou know there is nothing more energizing than being in a room of like-minded people. Like you\, they are willing to take time away from the office to learn something new. When you sit in sessions or have lunch at a table with new friends at this year’s Executive War College\, you’ll discover that you’re not alone in wanting to improve your skills and bring something back to your office or organization. They readily share their enthusiasm and lessons learned so you can take the best ideas back to your laboratory. \n\n\n\n\n\n\n\n\n\n\n\n\n9) Build Relationships with Existing Clients and Connect with New Prospects\n\n\n\n\nMore than 1\,000 people attended last year’s Executive War College. That fact alone guarantees that your company will interact with your major lab clients and the senior lab administrators and executives from lab organizations that should be doing business with your company. \n\n\n\n\n\n\n\n\n\n\n\n\n10) Have Fun!\n\n\n\n\nThis may not be the most important of all these 10 reasons\, but it shouldn’t be left off the list. The Executive War College is fun! Live events with other people are fun! People get better by attending conferences. By sitting at lunch tables with people you don’t (yet) know\, you’ll make amazing connections and even new friends by going to live events. Plus\, the host city is New Orleans\, world-famous for great cooking and good times. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat you’ll Experience at EWC\n\n\n\n\n\n\n\n\n\n116+ Top-flight\, information packed sessions\, panels\, and roundtables designed exclusively for laboratory and pathology executives and their teams\n169+ Expert Presenters delivering unique content full of exclusive advice and insights that you can’t get anywhere else\n1\,000+ colleagues all gathered in one place\, all focused on the business of clinical laboratories and pathology groups\nAccess to dozens of the industry’s leading vendors and the products\, services\, and ideas they bring to the table that can help your business\nInnovative strategies and ideas for your lab and pathology group to provide state-of-the art diagnostic services\, expand market share\, and tap new sources of much-needed revenue for 2026 and beyond\nDiscussion\, debate\, and networking for two full days at a gathering of the best and brightest in our profession so that you get as much value from networking opportunities as you do from the top-flight sessions and speakers\nTeam building opportunities to learn together and then implement the techniques\, strategies\, and information you’ve gained upon your return to your organization\n\nThis conference is designed to help you and your team learn how you can: \n\n\n\nTap new sources of revenue\nGenerate more revenue from your lab’s test claims\nCut costs in your lab\nSave money in your lab\nProvide state-of-the-art diagnostic services\nIdentify the new needs of physicians\, patients\, and hospitals\nAnd more!
URL:https://www.pathologynews.com/event/31st-annual-executive-war-college/
LOCATION:Hyatt Regency Hotel\, New Orleans\, LA\, United States\, New Orleans\, LA\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/31st-Annual-Executive-War-College.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260427T140000
DTEND;TZID=Europe/London:20260427T150000
DTSTAMP:20260826T233116
CREATED:20260323T133351Z
LAST-MODIFIED:20260323T133351Z
UID:100119827-1777298400-1777302000@www.pathologynews.com
SUMMARY:Foundation Models in Oncology: Why Benchmark Success Does Not Translate to Clinical Practice
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Duan Zhiyun from Fudan University\, China. \nAbstract\nFoundation models are rapidly reshaping biomedical research and hold great promise for oncology. Yet despite impressive benchmark performance\, their impact in real clinical settings remains limited. A key reason is that most current models are designed as narrow specialists optimized for static tasks\, while clinical oncology requires more generalist systems. Effective clinical support demands models that can integrate multimodal information\, follow the longitudinal course of disease\, and incorporate patient perspectives into decision-making. Rethinking model design along these dimensions will be crucial if foundation models are to move beyond benchmarks and become trusted partners in cancer care. \nRegister NowBio\nDuan is a medical doctor at Zhongshan Hospital of Fudan University\, Shanghai\, China. He has published as first author in several great journals in medicine\, including Cell Reports Medicine\, Nature Cancer\, and Journal of Translational Medicine over the past three years.
URL:https://www.pathologynews.com/event/foundation-models-in-oncology-why-benchmark-success-does-not-translate-to-clinical-practice/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/03/TIA-Centre-Seminar-Series-Foundation-Models-in-Oncology-Why-Benchmark-Success-Does-Not-Translate-to-Clinical-Practice.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260424T080000
DTEND;TZID=America/Los_Angeles:20260424T090000
DTSTAMP:20260826T233116
CREATED:20260323T160016Z
LAST-MODIFIED:20260327T125322Z
UID:100119837-1777017600-1777021200@www.pathologynews.com
SUMMARY:AI Powered QC Where You Need It: Finding Needles in the Haystack
DESCRIPTION:0000Days00Hrs00Min00SecThrough live demonstrations\, and interactive discussions\, attendees will understand the prevalence of artifacts and challenges of manual quality control (QC) for whole slide imaging (WSI). Learn how AI-powered QC helps labs identify the minority of slides with artifacts\, freeing up technician time to focus on the critical few. Innovative\, cutting-edge rescan functionality is designed to fix scanning problems before you know you have them. Aperio iQC software works in tandem with the Aperio GT range of scanners to automatically rescan slides\, with parameters optimized to resolve scan issues\, providing full autonomy\, with the confidence of complete control. Learn how Leica Biosystems’ Aperio iQC software detects artifacts early in the digital pathology workflow\, surfaces results in a centralized dashboard\, alerts the laboratory via the scanner console\, and supports faster\, more consistent quality control. \nLearning Objectives\n\nChallenges and bottlenecks in manual QC\, and how AI-powered QC helps eliminate unnecessary reviews\, and focus only on slides needing attention.\nHow Aperio iQC works in practice\, including the prevalence of artifacts\, where they are detected\, how results appear in the dashboard and scanner console\, and how slides are reviewed and addressed.\nHow to act faster and more consistently on QC findings\, using early artifact visibility to support timely decisions while slides remain in the scanning workflow.\n\nFor Research Use Only. Not for Use in Diagnostic Procedures \nRegister NowSpeakers\nProf. Cleo‑Aron Weis\, MD\, MSc\nHead of Section Computational Pathology\nInstitute of Pathology\, Medical Faculty Heidelberg\, Heidelberg University  \nProf. Cleo‑Aron Weis\, MD\, MSc is a board‑certified pathologist and recognized expert in digital pathology. He brings a unique interdisciplinary background that bridges clinical pathology\, medical physics\, and computational image analysis. His work focuses on morphological tumor heterogeneity\, digital pathology workflows\, and the application of advanced image analysis to improve diagnostic insight and research outcomes. He received his medical degree and Dr. med. from Ruprecht‑Karls‑Universität Heidelberg and holds two Master of Science degrees in Medical Physics\, with a strong emphasis on digital image processing and computational analysis\, including work on HER2/neu classification. Prof. Weis completed his pathology residency and research training at Universitätsmedizin Mannheim and has held senior clinical and academic appointments at both Mannheim and Heidelberg University hospitals. Through his clinical practice and academic research\, Prof. Weis is deeply engaged in advancing the role of digital and computational pathology in modern diagnostics and translational research. \nCatherine Conway\, PhD\nDirector of Clinical AI Applications\nDigital Pathology\, Leica Biosystems  \nDr. Catherine Conway is an accomplished technical leader with more than two decades of experience in Digital Pathology\, Image Analysis/AI\, and Product Development. She has led high impact scientific and technological initiatives across academia\, medical device companies\, and innovative startups\, to advance both research and clinical practice. Her career is distinguished by a strong ability to bridge scientific rigor with practical\, real-world application\, including extensive work in highly regulated environments\, augmented with a strong publication record. Dr. Conway holds a BSc in Biotechnology and a PhD in Digital Pathology from Dublin City University\, Ireland. She later completed a prestigious Postdoctoral Fellowship at the National Cancer Institute (NCI)\, National Institutes of Health (NIH) in the United States. She is deeply committed to translating scientific innovation into impactful tools and workflows that improve patient outcomes and contribute to meaningful medical progress.
URL:https://www.pathologynews.com/event/ai-powered-qc-where-you-need-it-finding-needles-in-the-haystack/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260417
DTEND;VALUE=DATE:20260423
DTSTAMP:20260826T233116
CREATED:20250711T145924Z
LAST-MODIFIED:20251117T125552Z
UID:100114347-1776384000-1776902399@www.pathologynews.com
SUMMARY:AACR Annual Meeting 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe AACR Annual Meeting is the focal point of the cancer research community\, where scientists\, clinicians\, other health care professionals\, survivors\, patients\, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology\, translational\, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world. \nRegister NowMeet Our Partner
URL:https://www.pathologynews.com/event/aacr-annual-meeting-2026/
LOCATION:San Diego Convention Center\, San Diego\, CA\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/AACR-Annual-Meeting-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260416T160000
DTEND;TZID=Europe/London:20260416T170000
DTSTAMP:20260826T233116
CREATED:20260402T132342Z
LAST-MODIFIED:20260402T132342Z
UID:100120080-1776355200-1776358800@www.pathologynews.com
SUMMARY:Why Aiforia’s Foundation Engine is Advancing Digital Pathology
DESCRIPTION:0000Days00Hrs00Min00SecThis webinar will start at 5 pm CEST\, 6 pm EEST\, 11 am pm EDT \nAI model development used to be a marathon of data and time\, but we have built a shortcut. Join Aiforia’s CPO and Director of Software Development to discover how Aiforia’s Foundation Engine elevates your research and diagnostics. \nThis session explores the design principles of Aiforia’s Foundation Engine and explains how this patent-pending technology sets a new benchmark for high-performance pixel-level image analysis and clinical-grade quality. \nPanu Kauppila\, M.Sc. (Tech.)\, Aiforia’s Chief Product Officer\, together with Yrjö Häme\, Ph.D.\, Aiforia’s Director of Software Development\, explain how pre-trained foundation models reduce AI model development timelines\, improve robustness\, and\, when combined with pathologists’ task-specific annotations\, provide even greater precision in clinical workflows. They will dive into Foundation Engine’s unparalleled technological architecture and capabilities\, enabling faster development and better generalization than with models based on convolutional neural networks. \nWhat will the session cover\n\nTechnology: analyzing the “under the hood” mechanics that power the Foundation Engine\nBenefits: maximizing AI model development throughput and expert-level precision with significantly less training data and manual effort while remaining cost-effective\nIntegration: how to access and deploy Foundation Models within the platform\nPractical examples: real-world use cases and performance results in Aiforia.\n\nWho should join?\n\nClinical pathologists seeking more robust and transparent AI tools\nDigital pathology innovators looking for the ultimate shortcut to high-performance AI models\nResearchers aiming to scale their throughput with less training data\nLab directors and managers aiming to increase diagnostic throughput and ensure reproducibility across clinical workflows\n\nRegister NowPresenters\nPanu Kauppila\, M.Sc. (Tech.)\nChief Product Officer\nAiforia \nPanu Kauppila is the Chief Product Officer (CPO) of Aiforia\, playing a key role in defining Aiforia’s product portfolio and prioritizing product development. He has more than 25 years of experience in productization and management of innovation in the medical technology sector in international companies. Thus\, Panu has a profound understanding of how\, with strong technological expertise\, scalable products can be built on top of a software platform for demanding preclinical and clinical use. He holds an M.Sc. in Physics and Medical Technology. \nYrjö Häme\, Ph.D.\nDirector of Software Development\nAiforia \nPanu Kauppila is the Chief Product Officer (CPO) of Aiforia\, playing a key role in defining Aiforia’s product portfolio and prioritizing product development. He has more than 25 years of experience in productization and management of innovation in the medical technology sector in international companies. Thus\, Panu has a profound understanding of how\, with strong technological expertise\, scalable products can be built on top of a software platform for demanding preclinical and clinical use. He holds an M.Sc. in Physics and Medical Technology.
URL:https://www.pathologynews.com/event/why-aiforias-foundation-engine-is-advancing-digital-pathology/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/04/Why-Aiforias-Foundation-Engine-is-Advancing-Digital-Pathology.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260416T160000
DTEND;TZID=UTC:20260416T170000
DTSTAMP:20260826T233116
CREATED:20260302T141300Z
LAST-MODIFIED:20260302T141300Z
UID:100119058-1776355200-1776358800@www.pathologynews.com
SUMMARY:HALO AP 2.5 Sneak Peek Webinar
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar starts at 8:00 PDT\, 11:00 EDT\, 16:00 BST \nLearn about the exciting new features in the 2.5 versions of HALO AP®!\n\n  \n\nSummary\n\n\n\n\nJoin us for a 1-hour webinar showcasing the latest advancements in HALO AP® version 2.5. Our robust digital pathology platform has been enhanced to support multi-site deployments\, new tools for the pathologist\, enhanced toolkit for collaboration\, and new Lab Logic capabilities. Hallie Rane\, Associate Product Manager for Clinical Applications at Indica Labs\, will demonstrate HALO AP’s Lab Logic capabilities\, highlighting recent improvements and exciting new features that make it easier to configure workflows combining AI results\, rules\, thresholds\, and manual review steps. Lab Logic brings these elements together in a single\, cohesive model\, giving labs more control over how decisions are made and actions are triggered across the platform.  \nHallie will also highlight updates to the tumor board module version 2.0 and show attendees how the new tumor board features support complex diagnostics when multi-disciplinary collaboration is key. Hallie will also give a detailed overview of additional HALO AP 2.5 features which include robust functionality and improved support for multi-site institutions including smart slide lists and profiles; site-specific reporting on a single platform; secondary assignee workflows; and multi-specimen support for a truly comprehensive bench-to-bedside workflow.  \n\n\n\n  \n\n\nLearning Objectives\n\n\n\n\n\nUnderstand the functionality of the HALO AP®platform and how it supports image and case management in anatomic pathology.\nUnderstand how Lab Logic provides a unified way to define\, manage and automate workflow behavior across AI and manual processes.\nDiscover new and improved collaboration tools for support of complex diagnostics and multi-disciplinary team meetings and learn how these new features support large medical institutions and multi-site deployments.\nIdentify how the new features in HALO AP 2.5 work together to create a configurable\, fully automatic\, AI-ready workflow for bench-to-bedside support. \n\n\n\nHALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe\, the UK\, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition\, HALO AP® provides built-in compliance with FDA 21 CFR Part 11\, HIPAA\, and GDPR. WBS-MAR-000020v1 \n\nRegister Now\nPresenter\n\nHallie RaneAssociate Product Manager for Clinical Applications Indica Labs  \nHallie Rane received a BS in biology from the University of New Mexico and has a background in molecular biology and evolution. Hallie joined Indica Labs in 2023 as the Product Specialist for HALO AP. Prior to Indica Labs\, Hallie worked in both industry and academic positions and has held a variety of technical and customer-facing roles\, where she collaborated with customers\, scientists\, and technicians to develop a diverse array of products. Her journey encompassed ventures into biotechnology innovation\, academic research labs\, and even the realm of craft beer production\, where she served as Head Brewer. 
URL:https://www.pathologynews.com/event/halo-ap-2-5-sneak-peek-webinar/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/HALO-AP-webinar_800x600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260413T143000
DTEND;TZID=Europe/London:20260413T153000
DTSTAMP:20260826T233116
CREATED:20260323T132633Z
LAST-MODIFIED:20260323T132633Z
UID:100119823-1776090600-1776094200@www.pathologynews.com
SUMMARY:SAGE: Agentic Framework for Interpretable and Clinically Translatable Computational Pathology Biomarker Discovery
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Sahar Almahfouz Nasser from Emory University\, USA. \nAbstract\nDespite significant progress in computational pathology\, many AI models remain black-box and difficult to interpret\, posing a major barrier to clinical adoption due to limited transparency and explainability. This has motivated continued interest in engineered image-based biomarkers\, which offer greater interpretability but are often proposed based on anecdotal evidence or fragmented prior literature rather than systematic biological validation. We introduce SAGE (Structured Agentic system for hypothesis Generation and Evaluation)\, an agentic AI system designed to identify interpretable\, engineered pathology biomarkers by grounding them in biological evidence. SAGE integrates literature-anchored reasoning with multi-modal data analysis to correlate image-derived features with molecular biomarkers\, such as gene expression\, and clinically relevant outcomes. By coordinating specialized agents for biological contextualization and empirical hypothesis validation\, SAGE prioritizes transparent\, biologically supported biomarkers and advances the clinical translation of computational pathology. \nRegister NowBio\nDr. Sahar Almahfouz Nasser is a postdoctoral researcher at Emory University’s Madabhushi Lab\, working at the intersection of computational pathology\, agentic AI\, and translational oncology. She is the creator of SAGE\, an agentic framework for biologically grounded and clinically translatable biomarker discovery\, with a focus on interpretable and trustworthy AI for cancer care. She is a recipient of the Qualcomm Innovation Fellowship\, and her work has been published in leading AI and medical imaging venues.
URL:https://www.pathologynews.com/event/sage-agentic-framework-for-interpretable-and-clinically-translatable-computational-pathology-biomarker-discovery/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/03/TIA-Centre-Seminar-Series-SAGE-Agentic-Framework-for-Interpretable-and-Clinically-Translatable-Computational-Pathology-Biomarker-Discovery.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T150000
DTEND;TZID=Europe/London:20260409T160000
DTSTAMP:20260826T233116
CREATED:20260310T104319Z
LAST-MODIFIED:20260310T154422Z
UID:100119214-1775746800-1775750400@www.pathologynews.com
SUMMARY:From Research to Routine: High-Throughput Spatial Biology with ZEISS and Mindpeak
DESCRIPTION:0000Days00Hrs00Min00SecAs the demand for complex biomarker analysis and precision oncology grows\, organizations face significant hurdles in scaling multiplex immunofluorescence (mIF) and spatial biology for high-throughput production. Traditional spatial workflows are often fragmented\, relying on manual processes and complex image analysis pipelines that require hundreds of hours of training and specialized bioinformatics expertise. \nIn this webinar\, we explore how to eliminate these bottlenecks and transition spatial biology from a low-throughput research tool into a robust\, production-ready environment that delivers images in and results out. We will dive into the integrated\, end-to-end solution developed by ZEISS and Mindpeak\, designed to seamlessly connect reagents\, high-speed scanning\, and automated image analysis. Attendees will learn how the ZEISS AxioScan 7 Spatial Biology enables standardized\, clinical-routine-ready imaging capable of processing up to 100 slides per day. \nFurthermore\, we will demonstrate how Mindpeak’s PhenoScout AI provides a “Turn-key” analysis experience\, allowing users to bypass months of algorithm training and achieve expert-grade\, single-cell precision without requiring any prior image analysis expertise. \nJoin us to discover how this seamless integration minimizes data handling complexities\, accelerates time-to-insight\, and ultimately establishes a reliable pathway from translational research and clinical trials to future diagnostic assays. \nLearning Objectives\n\nIdentify key hurdles of bringing mIF/spatial biology into high-throughput production.\nDiscuss solutions on the reagents\, scanner\, workflow\, and image analysis parts of the workflow\, with an emphasis on PhenoScout by Mindpeak.\nEvaluate the requirements for transitioning from manual research protocols to clinical-routine-ready imaging ecosystems.\n\nWhat We Will Cover\n\nHigh-Throughput Imaging: How the ZEISS AxioScan 7 enables standardized\, clinical-grade imaging for up to 100 slides per day.\nTurn-key AI Analysis: How Mindpeak’s PhenoScout AI provides expert-grade\, single-cell precision without requiring prior image analysis or algorithm training.\nClinical Pathways: How this integration minimizes data handling\, accelerates time-to-insight\, and establishes a reliable path from research to future diagnostic assays.\n\nKey Takeaways\n\nSpatial biology is now ready for production: Organizations can finally scale complex spatial workflows without sacrificing speed or reliability.\nUnlocking Massive Scale and Reliability (ZEISS Advantage): Achieve unprecedented throughput and standardization. By providing a highly reproducible\, clinical-routine-ready imaging ecosystem\, ZEISS allows labs to confidently process up to 100 slides per day\, establishing a clear pathway from translational research to regulatory clearance.\nEliminating the Analysis Bottleneck (Mindpeak Advantage): Experience “Zero Friction” spatial analysis. Mindpeak’s clinically validated AI completely removes the need for specialized bioinformatics expertise or months of software training. Users get immediate\, expert-grade precision\, freeing them to focus entirely on actionable biology rather than managing complex IT infrastructure.\nA Seamless\, End-to-End Clinical Pathway: Together\, ZEISS and Mindpeak deliver a fully automated\, end-to-end solution. From standardized high-quality image acquisition to instant\, reproducible biomarker reporting\, the integrated workflow minimizes data handling complexities and accelerates time-to-insight for high-throughput clients.\nReduced Operational Overhead: Automation of both hardware and software steps significantly lowers the cost-per-slide and reduces human error\, making spatial biology a viable option for large-scale clinical trials.\nStandardization for Future Diagnostics: This integrated approach provides the data consistency and quality control necessary to move biomarkers from the discovery phase toward validated clinical assays.\n\nRegister NowSpeakers\nDr. Moritz Widmaier \nExpert in Spatial Biology & Digital Pathology \nZEISS Research Microscopy Solutions \nDr. Moritz Widmaier is a recognized leader in spatial biology\, digital pathology\, and biomarker data analytics. Currently at ZEISS Research Microscopy Solutions\, he drives innovation in spatial biology workflows\, focusing on automation\, AI-powered image analysis\, and advanced imaging solutions like the ZEISS Axioscan 7 spatial Biology. \nWith a Ph.D. in Biochemistry and a unique ability to bridge the gap between complex biology and data science\, Dr. Widmaier has a proven track record of developing cutting-edge AI and data analytics products. Prior to ZEISS\, he held pivotal scientific and product leadership roles at industry-leading companies\, including Definiens\, AstraZeneca and Ultivue. \nHis extensive expertise spans across (immuno-) oncology\, multiplex immunofluorescence reagent chemistry and assay development and machine learning. Today\, Dr. Widmaier specializes in helping researchers leverage automated imaging and AI to turn intricate spatial data into reproducible\, actionable clinical and research insights. \nDr. Fabian Schneider \nSenior Product Manager \nMindpeak \nFabian Schneider\, PhD\, is Senior Product Manager at Mindpeak\, where he shapes the development and delivery of AI solutions for pathology. He has more than a decade of experience across leading organisations in computational pathology\, oncology and biomarker research. His career has spanned both scientific and product leadership\, from contributing to the establishment of automated data reporting for digital pathology assay data supporting clinical oncology studies at Roche\, to advancing computational pathology pipelines at AstraZeneca and leading product development for research solutions at Visiopharm. \nWith a doctorate from the University Hospital Frankfurt focused on Wnt signalling in tumour formation and angiogenesis\, followed by postdoctoral research at the Karolinska Institutet and the Technical University of Munich\, Dr. Schneider combines scientific depth with hands-on experience in product strategy and clinical translation. At Mindpeak\, he draws on this background to guide the development of AI tools that are scientifically robust\, clinically relevant and aligned with the needs of pathologists worldwide.
URL:https://www.pathologynews.com/event/from-research-to-routine-high-throughput-spatial-biology-with-zeiss-and-mindpeak/
LOCATION:Online
CATEGORIES:Live Online Webinar,PN Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/03/min-web0-assets.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260409
DTEND;VALUE=DATE:20260412
DTSTAMP:20260826T233116
CREATED:20260109T120601Z
LAST-MODIFIED:20260109T120601Z
UID:100117812-1775692800-1775951999@www.pathologynews.com
SUMMARY:14th World Digital Pathology and AI UCG Congress
DESCRIPTION:0000Days00Hrs00Min00SecThe 14th World Digital Pathology & AI UCGCongress is a specialised event focused on the intersection of pathology and digital technology. The congress serves as a platform for sharing knowledge\, exploring innovation\, and discussing emerging trends in digital pathology. \nThe programme offers opportunities to address key challenges in the field\, including digital pathology\, artificial intelligence in pathology\, machine learning\, computational pathology\, and related disciplines\, alongside practical and applied perspectives. The congress brings together experts from across academia\, clinical practice\, and industry to foster discussion\, collaboration\, and knowledge exchange. \nKey Highlights:\n\nCutting-Edge Topics: Covering Digital Pathology\, AI\, Image Analysis\, Telepathology\, Translational Research\, Tissue Imaging\, and more.\nRenowned Speakers: Leading experts in pathology\, AI\, and healthcare innovation.\nWorkshops & Panel Discussions: Hands-on sessions and expert-led panels on emerging trends.\nNetworking Opportunities: Meet global pathologists\, AI specialists\, researchers\, and industry leaders.\nPoster & Oral Presentations: Showcase groundbreaking research in digital pathology and AI.\nExhibition & Sponsorship: Discover innovative solutions from industry pioneers.\nCME & CPD Accreditation: Earn Continuing Medical Education (CME) and Continuing Professional Development (CPD) credits\n\nRegister Now
URL:https://www.pathologynews.com/event/14th-world-digital-pathology-and-ai-ucg-congress/
LOCATION:Dubai\,UAE\, Dubai\, United Arab Emirates
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/14th-World-Digital-Pathology-and-AI-UCG-Congress.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260408T160000
DTEND;TZID=UTC:20260408T170000
DTSTAMP:20260826T233116
CREATED:20260402T161306Z
LAST-MODIFIED:20260402T161306Z
UID:100120087-1775664000-1775667600@www.pathologynews.com
SUMMARY:Advancing Imaging Interoperability Together: A DPA-CAP-SIIM Collaboration to Improve Standardized Workflow Adoption
DESCRIPTION:0000Days00Hrs00Min00SecOverviewInteroperability across medical imaging is no longer optional—it is foundational to the future of connected\, scalable\, and patient-centered care. In this webinar\, we will review results from the recent SIIM-DPA-CAP DICOM Toolkit Survey and discuss what they reveal about the current state of standards adoption in digital pathology. Additionally\, the session will examine the critical role of DICOM and IHE in supporting consistent imaging metadata and enabling interoperability across pathology\, radiology\, and other imaging-rich specialties. A panel featuring representatives from DPA\, CAP\, SIIM and pathologists with standards based interoperability\, including deployment for clinical use\, will share perspectives on current challenges\, emerging opportunities\, and the importance of coordinated action. \nLearning ObjectivesBy the end of this webinar\, participants will be able to: \n\nSummarize the key findings of the recent DICOM Toolkit Survey and their implications for standards adoption and interoperability in medical imaging.\nDescribe the importance of DICOM and IHE standards in supporting consistent\, interoperable imaging metadata across pathology\, radiology\, and other imaging domains.\nDiscuss the role of DPA in accelerating cross-organizational collaboration in advancing practical interoperability for clinical care\, operations\, and innovation.\n\nRegister NowPresentersAlexander Towbin\, MD\, FAAP\, FACR\, FSIIM\, FICIS\nCincinnati Children’s Hospital Medical Center \nAlexander J. Towbin\, MD is Professor of Radiology and the Neil D. Johnson Chair of Radiology Informatics at Cincinnati Children’s Hospital Medical Center. He also serves as Associate Chief of Radiology\, Associate Chief Medical Information Officer\, and Associate Chief of Staff. Internationally recognized for advancing pediatric radiology\, imaging informatics\, and quality improvement\, he brings particular expertise in abdominal and cancer imaging and in the use of imaging data to improve clinical care and interoperability across the healthcare enterprise. \nA prolific scholar and educator\, Dr. Towbin has delivered invited lectures worldwide and published more than 400 manuscripts and 150 book chapters. He currently serves as Chair-Elect of the Society for Imaging Informatics in Medicine and previously served as co-chair of the HIMSS–SIIM Enterprise Imaging Community. His work bridges clinical care\, research\, and informatics to improve outcomes for children\, families\, and the healthcare workforce. \nKevin Schap\, MScBMI\nDirector of Clinic Informatics\, Digital Pathology\, and Data Science\nCollege of American Pathologists \nKevin Schap\, MScBMI\, is Director of Clinical Informatics\, Digital Pathology\, and Data Science at the College of American Pathologists. He specializes in advancing digital pathology standards\, with expertise in DICOM whole slide imaging (WSI) and IHE Pathology and Laboratory Medicine (PaLM) interoperability frameworks. Kevin oversees multiple CAP initiatives\, including the AI Committee\, Digital and Computational Pathology Committee\, Informatics Committee\, and the Council on Informatics and Pathology Innovation. His work focuses on accelerating standards adoption and developing educational strategies that empower pathologists to effectively evaluate and integrate artificial intelligence tools into clinical practice. \nMustafa Yousif\, MD\nUniversity of Michigan \nDr. Mustafa Yousif is the Associate Chief Medical Information Officer\, Associate Director of Pathology Informatics\, Assistant Professor of Pathology Informatics\, and Medical Director of Digital Pathology at the University of Michigan. He completed his anatomical and clinical pathology residency at Wake Forest University\, followed by fellowships in Gynecologic and Breast Pathology at the University of Pittsburgh Medical Center and Pathology Informatics at the University of Michigan. Dr. Yousif serves as Co-chair of DICOM WG-26: Pathology. His research focuses on digital pathology\, artificial intelligence\, computer vision\, and image analysis\, alongside gynecologic and breast pathology. \nModeratorsJohn Groth\, MD\, Pathologist\,Endeavor Health \nJennifer Samboy\, MHA\, Digital Transformation Leader\, Philips Digital & Computational Pathology
URL:https://www.pathologynews.com/event/advancing-imaging-interoperability-together-a-dpa-cap-siim-collaboration-to-improve-standardized-workflow-adoption/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/04/Advancing-Imaging-Interoperability-Together-A-DPA-CAP-SIIM-Collaboration-to-Improve-Standardized-Workflow-Adoption.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260408
DTEND;VALUE=DATE:20260412
DTSTAMP:20260826T233116
CREATED:20260115T131319Z
LAST-MODIFIED:20260115T131355Z
UID:100117905-1775606400-1775951999@www.pathologynews.com
SUMMARY:International Symposium on Biomedical Imaging 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe IEEE International Symposium on Biomedical Imaging (ISBI) is a premier scientific conference dedicated to the mathematical\, algorithmic\, and computational aspects of biological and biomedical imaging across all scales of observation. \nIt fosters knowledge transfer among different imaging communities and contributes to an integrative approach to biomedical imaging. ISBI is a joint initiative of the IEEE Signal Processing Society (SPS) and the IEEE Engineering in Medicine and Biology Society (EMBS). \nRegister Now
URL:https://www.pathologynews.com/event/international-symposium-on-biomedical-imaging-2026/
LOCATION:The ICC Capital Suite at ExCeL London\, Royal Victoria Dock\, 1 Western Gateway\, London\, e16 1xl\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/International-Symposium-on-Biomedical-Imaging.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260331T150000
DTEND;TZID=Europe/London:20260331T160000
DTSTAMP:20260826T233116
CREATED:20260302T135657Z
LAST-MODIFIED:20260302T135657Z
UID:100119049-1774969200-1774972800@www.pathologynews.com
SUMMARY:Masterclass: Unlock Cell Population Discovery Using HALO® High Dimensional Analysis
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar starts at 7:00 PDT\, 10:00 EDT\, 15:00 BST \nLearn how unbiased high-dimensional analysis can be seamlessly combined with AI-powered HALO workflows for multiplex images!\n\n\nSummary\n\n\n\n\nMultiplexed imaging generates rich datasets where extracting meaningful insights requires more than predefined gates.  \nIn this webinar\, we present a real-world use case analyzing tertiary lymphoid structures (TLS) in non-small cell lung cancer (NSCLC) using whole-slide multiplex immunofluorescence images acquired on the Orion™ platform (RareCyte). We demonstrate how standard HALO® workflows\, including AI-driven tissue classification and cell segmentation\, can be seamlessly combined with unbiased high-dimensional analysis\, all within the same software.  \nUsing K-means\, Phenograph\, and UMAP\, we explore phenotypic diversity within TLS from dense tumor regions and highly infiltrated zones. HALO® High Dimensional Analysis reveals biologically relevant differences between these zones beyond supervised phenotypes. Importantly\, the dynamic link between UMAP plots and the original tissue image provides biological meaning to clustering results and enables clear spatial validation.  \n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nAssess sample cell composition “at a glance” using K-means and Phenograph. \nUse unsupervised analysis to quality control your analysis pipeline. \nNavigate interactively between the UMAP and biological image. \nApply an iterative\, data-driven strategy to identify and discover biologically relevant phenotypes. \n\n\n\n\nRegister Now\nPresenter\n\nDr. Ghislaine Lioux\nSenior Field Applications Scientist \nIndica Labs  \nDr. Ghislaine Lioux earned her PhD from the Spanish National Institute of Cardiovascular Research in Madrid as a Marie Curie Fellow\, where she studied molecular mechanisms of heart development. Ghislaine joined Indica Labs in 2020\, and in her current position as a Senior Field Applications Scientist she supports customers\, distributors\, and collaborators on the technical use of HALO software. 
URL:https://www.pathologynews.com/event/masterclass-unlock-cell-population-discovery-using-halo-high-dimensional-analysis/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/HDA-Webinar_800x600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260329
DTEND;VALUE=DATE:20260402
DTSTAMP:20260826T233116
CREATED:20251119T163834Z
LAST-MODIFIED:20260107T114447Z
UID:100116901-1774742400-1775087999@www.pathologynews.com
SUMMARY:Focus on Microscopy 2026
DESCRIPTION:FOM2026 continues a long-standing (since 1988)\, yearly conference series on the latest innovations and developments in (optical) microscopy and their application in biology\, medicine\, and the material sciences. \nTopics\n\nTheory and practice of confocal and multiphoton-excitation microscopy\nInstrumentation and microscope design\nSuper-resolution microscopy\n3D and 4D live cell and tissue imaging\nAdaptive optics for microscopy\nLight sheet microscopy\nPhase/interference based microscopies\nOCT\, holography\, endoscopy\nAdvanced fluorescence imaging/spectroscopy: FRET\, FRAP\, FLIM\, FCS\, SOFI\nNew fluorescent probes\, proteins\, quantum dots\, single molecule imaging\nClearing and expansion techniques\nCoherent non-linear microscopies: SHG\, THG\, SFG\, CARS\nMulti-dimensional fluorescence and Raman spectroscopy imaging\nCorrelated microscopies e.g. light/electron\nLaser manipulation and tracking\, photo-activation\nFast acquisition\, automated and high-content microscopy\n3D image processing and visualization for multidimensional data\n\nRegister Now
URL:https://www.pathologynews.com/event/focus-on-microscopy-2026/
LOCATION:Kistamässan\, Arne Beurlings Torg 5\, Kista\, Stockholm\, 164 40\, Sweden
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/Focus-on-Microscopy-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260328
DTSTAMP:20260826T233117
CREATED:20250820T144848Z
LAST-MODIFIED:20250821T092815Z
UID:100115194-1774224000-1774655999@www.pathologynews.com
SUMMARY:National Imaging Informatics Course - Spring 2026
DESCRIPTION:0000Days00Hrs00Min00SecLearn the fundamentals of Imaging Informatics.\n\n\n\n\nNational Imaging Informatics Course (NIIC)\, Borne out of our collaboration with the RSNA + DPA\, NIIC is the first of its kind to delve into comprehensive fundamental principles in today’s real-world ecosystem of imaging informatics. \n\n\n\n\n\n\nGet working knowledge fast with SIIM’s National Imaging Informatics Course (NIIC)\n\n\n\n\n\nThe National Imaging Informatics Course (NIIC) is an accelerated\, week-long online experience for imaging informaticists seeking to better leverage their expertise towards a broader\, more holistic engagement within the field. \nBorne out of our collaboration with the RSNA and DPA\, NIIC is the first of its kind to delve into comprehensive fundamental principles in today’s real-world ecosystem of imaging informatics – in order to create enduring engagement and innovation within the field. \nParticipants develop a well more well-rounded understanding of the field\, demystify business cases and become more confident\, effective and valuable in the fast-changing medical and healthcare fields – plus earn up to 20 hours of SIIM IIP Credits doing so! \nIt is the perfect opportunity to introduce non-radiology professionals to the field of imaging informatics\, gain relevant understanding of how medical/healthcare systems work in total and impact how patients are cared for every day. \nThis NIIC Term is made possible by a partnership between the Radiological Society of North America (RSNA)\, the Digital Pathology Association (DPA) and the Society for Imaging Informatics in Medicine (SIIM); and initially funded by a grant from the Association of University Radiologists (AUR)\, this course has been developed by a team of faculty comprised of experts in imaging informatics from around the world. \n\n\n\nRegister Now\n\nImaging Informatics for All\n\nNIIC is open to anyone across the healthcare enterprise seeking to gain a baseline understanding of imaging informatics\, advance cross-functional skillsets and invest in their career goals. \n\nIndividual professionals\nPracticing physicians\nInstitutions\nTrainees at all levels\nFaculty\nIT experts\nIndustry partners\nand more!\n\n\n\n\n\n\nKey Features\n\nNIIC’s specialized curriculum is packed with relevant exercises (and tips) across the imaging informatics spectrum that are essential to modern medicine/healthcare including: \n\nClinical workflow\nHardware/software/networking requirements\nStandards\nPatient-centric radiology\nPACS archives\nBusiness aspects\nHot topics: AI\, mission-learning\, data science\, and 3D printing\n\nThe course is efficiently structured with intellectually stimulating pre-work and well-thought-out agendas plus an ample 3-month window to complete homework assignments.
URL:https://www.pathologynews.com/event/national-imaging-informatics-course-spring-2026/
LOCATION:Online
CATEGORIES:Online Training
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/National-Imaging-Informatics-Course.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260321
DTEND;VALUE=DATE:20260327
DTSTAMP:20260826T233117
CREATED:20250918T152047Z
LAST-MODIFIED:20251117T125050Z
UID:100115674-1774051200-1774569599@www.pathologynews.com
SUMMARY:USCAP 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe meeting will kick off on Saturday\, March 21 with the USCAP Honors and Dr. John Goldblum delivering the Maude Abbott Legacy lecture\, followed by the all-attendee welcome reception\, Gathering in the Grotto\, held on the San Antonio River Walk. \nOn Sunday\, March 22th\, select from over 40 education sessions offered by Companion Societies. These sessions cover the breadth and depth of pathology and are an excellent chance for you to network with colleagues. Starting Monday\, March 23rd\, attendees can select from a variety of programming from platforms to Luminaries to Interactive Microscopy sessions. In addition\, attendees can visit the exhibit hall to view the latest and greatest in pathology and attend seminars to get a deep dive into new products and technologies. On Tuesday\, March 24th\, join the Nathan Kaufman Timely Topics lecture on Generative and Agentic AI for Pathology delivered by Dr. Faisal Mahmood. \nWhy Attend the Annual Meeting\n\nConnect With Pathology Legends: USCAP’s Annual Meeting is where you go to hear pathology legends share their insights; where you run into the authors of your textbooks at an afternoon lecture; and where you meet the leading minds in pathology and join the conversation!\nReconnect With Old Friends and Make New Ones: Reconnect with friends from previous schools or positions; chat with your fellow attendees at social events; share insights around the microscope in Interactive Microscopy courses; or tour the poster hall and find a new collaborator.\nConnect Your Ideas: Before it’s a eye-opening article in a USCAP journal\, it might be a poster at the Annual Meeting. USCAP attracts the most cutting-edge research to its Poster Hall\, Moderated Poster Sessions\, and Platform Sessions. Come talk to the researchers in person and see how your ideas might align!\nSee How Exhibitors Connect Ideas and Action: Browse the latest technology and innovative products at the Exhibit Hall. You’ll hear from all of the leading companies in the field and glimpse the future of daily pathology practice. Visit pathology associations\, find new educational tools\, and more.\n\nRegister Now
URL:https://www.pathologynews.com/event/uscap-2026/
LOCATION:San Antonio\, TX\, USA\, San Antonio\, TX\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/09/USCAP-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260319T170000
DTEND;TZID=Europe/London:20260319T180000
DTSTAMP:20260826T233117
CREATED:20260205T123809Z
LAST-MODIFIED:20260227T092746Z
UID:100118509-1773939600-1773943200@www.pathologynews.com
SUMMARY:The Cost of Disconnected Systems:  How to Leverage Pathology-Led Integrated Diagnostics on a Single Enterprise Platform
DESCRIPTION:0000Days00Hrs00Min00SecMost health systems are feeling the impact of fragmented diagnostic systems. Digital pathology may be live\, but radiology sits on a separate platform\, molecular data is handled elsewhere\, and AI tools often run as isolated pilots. These disconnects reduce the full potential of digital transformation and make effective collaboration more difficult. They also lead to avoidable delays\, add complexity to MDT meetings\, and increase IT and administrative burden. \nThis session takes a practical look at how digital pathology can anchor an integrated diagnostics strategy on a single enterprise imaging platform. We’ll focus on how leading AMCs and IDNs are approaching this transition\, why organizations are choosing an enterprise framework\, and what benefits they expect as they expand integrated workflows across pathology\, radiology\, and genomics. The discussion will highlight real-world decision-making\, early lessons learned\, and the long-term value of a unified diagnostic platform. \nLearning Objectives:\n\nHow fragmented diagnostic systems affect workflow\, collaboration\, and IT complexity\nWhy digital pathology is well positioned to lead an enterprise imaging strategy across departments\nHow health systems are approaching integrated diagnostics and the expected benefits of a single platform\n\nRegister NowPresenters\nTom Zarzycki \nAccount Manager\, MedicalDirector\, Strategic Development Digital Pathology | ImIT – Applications – Pathology \nJennifer Fralick  \nVice President of Anatomic Pathology and Clinical Laboratories at Stanford Health Care\, where she oversees all Stanford Medicine laboratory operations across the San Francisco Bay Area. In this role\, she has led major strategic initiatives\, including the implementation of two Digital Pathology platforms\, a comprehensive scanner ecosystem\, and Beaker AP. Under her leadership\, Stanford’s pathology and laboratory services expanded significantly to meet rising testing volumes and supported the growing complexity of molecular\, genetic\, and genomic diagnostics. She also played a central role in establishing and scaling Stanford’s COVID‑19 response. \nBefore joining Stanford\, Jennifer built a reputation as a highly regarded program manager at multiple academic medical centers. Her work included leading large‑scale implementations such as Radiology PACS systems\, Epic\, and automated chemistry lines—projects that required deep technical expertise\, operational insight\, and cross‑disciplinary coordination. \nOutside of her professional work\, Jennifer is an avid cyclist and runner. \nJonathan Shoemaker \nJonathan Shoemaker is an accomplished healthcare technology leader with nearly 30 years of experience advancing enterprise imaging\, workflow modernization\, and clinical informatics across major academic medical centers. As Executive Director of Imaging Systems and Services at Stanford Health Care\, he oversees a broad imaging portfolio and led the design of a highly resilient enterprise imaging platform that supports AI\, machine learning\, and real‑time research integration. Recently Mr. Shoemaker’s portfolio architected the latest Digital pathology platform that enables a full dicom deployment and informatics normalization model into Stanford digital pathology. \nPreviously\, at Sutter Health\, Jonathan directed one of the nation’s largest deconstructed PACS implementations\, consolidating 54 medical record systems and migrating 2PB of imaging data while building a new enterprise imaging support organization. His earlier consulting and engineering roles—spanning Ascendian Healthcare Consulting and GE Healthcare—shaped his reputation as a national expert in imaging architecture\, VNA strategy\, workflow optimization\, and complex multi‑system integration. \nRebecca Rojansky  \nDr. Rebecca Rojansky\, MD. PhD. is Associate Director for Clinical Pathology Informatics and Assistant Professor of Pathology at Stanford University School of Medicine. She is a practicing molecular and hematopathologist. Her work focuses on digital and computational pathology\, artificial intelligence\, and clinical informatics infrastructure to enable precision diagnostics.
URL:https://www.pathologynews.com/event/the-cost-of-disconnected-systems-how-to-leverage-pathology-led-integrated-diagnostics-on-a-single-enterprise-platform/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/02/sec-800x6000-updated-time.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260317T110000
DTEND;TZID=Europe/Paris:20260317T150000
DTSTAMP:20260826T233117
CREATED:20260121T131830Z
LAST-MODIFIED:20260121T131830Z
UID:100117999-1773745200-1773759600@www.pathologynews.com
SUMMARY:Indica Labs’ Frankfurt HALO® User Group Meeting
DESCRIPTION:0000Days00Hrs00Min00SecLearn about the latest advancements from Indica Labs and how our customers are leveraging HALO platforms and Indica Labs services to advance their digital pathology.\n\n\nSummary\n\n\n\n\nIndica Labs is pleased to announce our Frankfurt HALO® User Group Meeting at Hilton Frankfurt Airport on 17 March from 11:00 – 16:00. \nOur program this year features guest speakers sharing insightful real-world applications of our HALO platforms as well as presentations from Indica Labs exploring the latest advancements in image analysis\, image management\, and services. \nWe welcome anyone who is interested in learning more about Indica Labs’ quantitative digital pathology solutions to register for the meeting today and save your place. You do not need to be a current Indica Labs customer to attend\, and the full agenda will be shared soon. \n\n\nRegister Now
URL:https://www.pathologynews.com/event/indica-labs-frankfurt-halo-user-group-meeting/
LOCATION:Hilton Frankfurt Airport\, THE SQUAIRE\, Am Flughafen\, Frankfurt am Main\, 60549\, Germany
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/Frankfurt-User-Group-Meeting-800x600-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260313
DTSTAMP:20260826T233117
CREATED:20260305T111450Z
LAST-MODIFIED:20260305T111625Z
UID:100119112-1773014400-1773359999@www.pathologynews.com
SUMMARY:HIMSS USA 2026
DESCRIPTION:0000Days00Hrs00Min00SecHealthcare’s Premier Event\nGlobal Brands. Groundbreaking Ideas. Growth Opportunities. Genuine Connections. All Under One Roof.\nThe countdown to healthcare’s most transformative event has begun—and the prime opportunity to secure your spot starts now. HIMSS26 isn’t just a conference; it’s the epicenter of healthcare technology where groundbreaking solutions meet visionary minds. \nWhy Attend HIMSS 2026: Transform Healthcare Through Technology\nJoin the world’s largest healthcare IT gathering as we convene in Las Vegas from March 9-12\, 2026 for the HIMSS Global Health Conference & Exhibition. We’re bringing together healthcare IT professionals\, hospital executives\, technology vendors\, clinicians\, and industry leaders from around the globe to explore cutting-edge innovations that are reshaping the future of healthcare. \nThis premier event brings together the best minds in digital health\, creating the perfect opportunity to: \n\nDiscover Game-Changing Solutions\nGain Practical Knowledge\nBuild Valuable Connections\nMake the Most of Your HIMSS26 Experience\n\nRegister Now
URL:https://www.pathologynews.com/event/himss-2026/
LOCATION:The Venetian Convention & Expo Center\, 201\, Sands Avenue\, Las Vegas\, NV\, 89169\, United States
ATTACH;FMTTYPE=image/webp:https://www.pathologynews.com/wp-content/uploads/2026/03/HIMSS-USA-2026.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260305T130000
DTEND;TZID=UTC:20260305T140000
DTSTAMP:20260826T233117
CREATED:20260202T113505Z
LAST-MODIFIED:20260202T113505Z
UID:100118433-1772715600-1772719200@www.pathologynews.com
SUMMARY:Getting Started With HALO AI
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar starts at 8:00 EST\, 13:00 GMT\, 14:00 CET \nLearn how to develop your own AI algorithms for segmentation\, classification\, and more using HALO AI\n\n\n\n\nSummary\n\n\n\n\nJoin us for an exciting webinar where you’ll embark on the journey of developing your own AI algorithms using HALO AI. This comprehensive session will guide you through creating and refining AI algorithms included with HALO AI\, providing invaluable tips\, tricks\, and best practices along the way.   \nWhether your focus is on tissue detection\, nuclear detection\, membrane detection\, object/cell phenotyping\, or slide quality control\, HALO AI has you covered. Additionally\, we will delve deeper into the capabilities of the AI Object Phenotyper\, an advanced tool designed to classify cells without the requirement for biomarker positivity.  \nDon’t miss this opportunity to enhance your AI skills and leverage the powerful features of HALO AI. We look forward to seeing you there!  \n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nUnderstand the process of creating and training an algorithm using HALO AI \nLearn best practices for developing and training algorithms \nLearn about the capabilities and applications of AI-based object phenotyping\n\n\n\n\nRegister Now\nPresenter\n\nPedro Espinosa GonzalezSenior Field Applications Scientist – EMEA Indica Labs  \nPedro has a background in histology\, having worked in core facilities\, diagnostics units\, and research. During this time\, he specialized in cardiovascular\, neurological and oncological histology and developed an interest in image acquisition and image analysis giving him the opportunity to try different methods\, from WSI and confocal to super-resolution imaging and analysis. Pedro joined Indica Labs in 2022\, and in his current position as a Senior Field Applications Scientist provides applications support for HALO®\, HALO AI and HALO Link. 
URL:https://www.pathologynews.com/event/getting-started-with-halo-ai/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/02/Intro-to-AI_PN800x600.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260303T140000
DTEND;TZID=UTC:20260303T150000
DTSTAMP:20260826T233117
CREATED:20260220T113919Z
LAST-MODIFIED:20260225T133754Z
UID:100118825-1772546400-1772550000@www.pathologynews.com
SUMMARY:Analysis of computational tumor-infiltrating lymphocytes in breast cancer from the results of the TIGER challenge
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Mart van Rijthoven\, Radboud UMC\, Nijmegen\, The Netherlands. \nAbstract\nTumor-infiltrating lymphocytes (TILs) is a recognized prognostic biomarker in breast cancer. However\, poor interobserver agreement and limited reproducibility highlight the need for computational approaches. Despite advances\, adoption of computational models has been hindered by lack of standardized methods and robust benchmarks. To address this\, we launched TIGER\, an international competition to build open-source computational TILs (cTILs) models. Here\, we present a multi-centric analysis of cTILs methods on resections and biopsies from 3\,708 human epidermal growth factor receptor 2-positive (HER2+) and triple-negative breast cancers (TNBC) from clinical practice and phase 3 trials. We report benchmarks on image analysis performance\, show strong agreement of cTILs with pathologists\, and demonstrate positive association of cTILs with neoadjuvant therapy response in HER2+\, superior to visually scored TILs. We also show that cTILs add independent prognostic information to clinical variables in TNBC resections. Data\, methods and benchmarks are publicly available: https://tiger.grand-challenge.org/ \nRegister NowBio\nMart van Rijthoven did his PhD work in the Computational Pathology Group at Radboud University Medical Center\, focusing on deep learning for biomarker quantification in whole-slide images. His work includes the HookNet model\, quantification of tertiary lymphoid structures\, and few-shot learning for histopathology. He also developed the WholeSlideData package and co-organized the TIGER challenge.
URL:https://www.pathologynews.com/event/analysis-of-computational-tumor-infiltrating-lymphocytes-in-breast-cancer-from-the-results-of-the-tiger-challenge/
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/02/TIA-Centre-Seminar-Series-Analysis-of-computational-tumor-infiltrating-lymphocytes-in-breast-cancer-from-the-results-of-the-TIGER-challenge.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260224T083000
DTEND;TZID=UTC:20260224T183000
DTSTAMP:20260826T233117
CREATED:20251010T135639Z
LAST-MODIFIED:20251014T084718Z
UID:100116116-1771921800-1771957800@www.pathologynews.com
SUMMARY:PathVision 2026: The Convenzis NHS Pathology Strategy Conference North
DESCRIPTION:0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences\nPathology services are integral to the NHS\, supporting over 70% of clinical diagnoses. As demands on pathology continue to grow\, innovation in digital pathology\, automation\, and workforce management is essential. This conference will explore the latest advancements and strategies for ensuring efficiency\, accuracy\, and service sustainability. \nKey Topics:\n\nDigital pathology and AI-driven diagnostics\nAddressing staff shortages and training needs\nThe future of pathology networks\nImproving turnaround times and service integration\nInvestment and funding for pathology services\n\nRegister NowWhy Attend?\nThis annual event brings together NHS pathology professionals\, laboratory managers\, and clinical leaders to explore cutting-edge developments in diagnostics. Join the conversation and be part of shaping the future of pathology services.
URL:https://www.pathologynews.com/event/pathvision-2026-the-convenzis-nhs-pathology-strategy-conference-north/
LOCATION:etc venues Manchester\, 8th Floor\, 11 Portland Street\, Manchester\, M1 3HU\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/PathVision-2026-The-Convenzis-NHS-Pathology-Strategy-Conference-North.jpg
END:VEVENT
END:VCALENDAR